Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Brinkmann

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Cancer Genomics & Proteomics|October 25, 2020
Micro RNAs Promoting Growth and Metastasis in Preclinical <i>In Vivo</i> Models of Subcutaneous MelanomaUlrich H Weidle, Simon AuslÄnder, Ulrich Brinkmann
Cancer Genomics & Proteomics|April 24, 2023
Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical <i>In Vivo</i> ModelsUlrich H Weidle, Hung-En Hsia, Ulrich Brinkmann
Seminars in Oncology|December 3, 2014
Tumor-antigen-binding bispecific antibodies for cancer treatmentUlrich H Weidle, Roland E Kontermann, Ulrich Brinkmann
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Influence of TBK-1 on tumor angiogenesis and microvascular inflammationMarcus Czabanka, Christian Korherr, Ulrich Brinkmann, et al.
Bioinformatics (Oxford, England)|April 9, 2005
Common denominator procedure: a novel approach to gene-expression data mining for identification of phenotype-specific genesRené Korn, Sascha Röhrig, Steffen Schulze-Kremer, et al.
Cancer Genomics & Proteomics|December 29, 2019
MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic RelevanceUlrich H Weidle, Daniela Schmid, Fabian Birzele, et al.
Cancer Genomics & Proteomics|June 29, 2021
Gastric Cancer: Identification of microRNAs Inhibiting Druggable Targets and Mediating Efficacy in Preclinical <i>In Vivo</i> ModelsUlrich H Weidle, Fabian Birzele, Ulrich Brinkmann, et al.
Cancer Genomics & Proteomics|April 17, 2022
Circular RNAs With Efficacy in Preclinical <i>In Vitro</i> and <i>In Vivo</i> Models of Esophageal Squamous Cell CarcinomaUlrich H Weidle, Tatjana Sela, Ulrich Brinkmann, et al.
Anticancer Research|September 3, 2021
Down-regulated MicroRNAs in Gastric Carcinoma May Be Targets for Therapeutic Intervention and Replacement TherapyUlrich H Weidle, Fabian Birzele, Simon Auslaender, et al.
Cancer Genomics & Proteomics|December 17, 2013
The translational potential for target validation and therapy using intracellular antibodies in oncologyUlrich H Weidle, Daniela Maisel, Ulrich Brinkmann, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Cancer Genomics & Proteomics|October 25, 2020
Micro RNAs Promoting Growth and Metastasis in Preclinical <i>In Vivo</i> Models of Subcutaneous MelanomaUlrich H Weidle, Simon AuslÄnder, Ulrich Brinkmann
Cancer Genomics & Proteomics|April 24, 2023
Breast Cancer: Circular RNAs Mediating Efficacy in Preclinical <i>In Vivo</i> ModelsUlrich H Weidle, Hung-En Hsia, Ulrich Brinkmann
Seminars in Oncology|December 3, 2014
Tumor-antigen-binding bispecific antibodies for cancer treatmentUlrich H Weidle, Roland E Kontermann, Ulrich Brinkmann
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Influence of TBK-1 on tumor angiogenesis and microvascular inflammationMarcus Czabanka, Christian Korherr, Ulrich Brinkmann, et al.
Bioinformatics (Oxford, England)|April 9, 2005
Common denominator procedure: a novel approach to gene-expression data mining for identification of phenotype-specific genesRené Korn, Sascha Röhrig, Steffen Schulze-Kremer, et al.
Cancer Genomics & Proteomics|December 29, 2019
MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic RelevanceUlrich H Weidle, Daniela Schmid, Fabian Birzele, et al.
Cancer Genomics & Proteomics|June 29, 2021
Gastric Cancer: Identification of microRNAs Inhibiting Druggable Targets and Mediating Efficacy in Preclinical <i>In Vivo</i> ModelsUlrich H Weidle, Fabian Birzele, Ulrich Brinkmann, et al.
Cancer Genomics & Proteomics|April 17, 2022
Circular RNAs With Efficacy in Preclinical <i>In Vitro</i> and <i>In Vivo</i> Models of Esophageal Squamous Cell CarcinomaUlrich H Weidle, Tatjana Sela, Ulrich Brinkmann, et al.
Anticancer Research|September 3, 2021
Down-regulated MicroRNAs in Gastric Carcinoma May Be Targets for Therapeutic Intervention and Replacement TherapyUlrich H Weidle, Fabian Birzele, Simon Auslaender, et al.
Cancer Genomics & Proteomics|December 17, 2013
The translational potential for target validation and therapy using intracellular antibodies in oncologyUlrich H Weidle, Daniela Maisel, Ulrich Brinkmann, et al.
Pageof 10